Tuyen Bui
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
Papers in
- Oncology 24
- Cancer-related Molecular Pathways 19
-
- Epigenetics and DNA Methylation 4
- DNA Repair Mechanisms 3
- Ubiquitin and proteasome pathways 3
- RNA modifications and cancer 3
- Co-authors
- Khandan Keyomarsi (34 shared papers)Kelly K. Hunt (26 shared papers)Cansu Karakaş (10 shared papers)Smruthi Vijayaraghavan (6 shared papers)Saïd Akli (6 shared papers)Lisa D. Auckland (2 shared papers)Yi Zhou (2 shared papers)Min Yi (5 shared papers)
- Journals
- Cancer Research (17 papers)Oncogene (3 papers)Clinical Cancer Research (2 papers)Molecular Cancer Therapeutics (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
Tuyen Bui
35 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 85
- Oncology 603
- Cancer Research 192
- Pulmonary and Respiratory Medicine 377
- Cell Biology 174
- Molecular Biology 549
Countries citing papers authored by Tuyen Bui
This map shows the geographic impact of Tuyen Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuyen Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuyen Bui more than expected).
Fields of papers citing papers by Tuyen Bui
This network shows the impact of papers produced by Tuyen Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuyen Bui. The network helps show where Tuyen Bui may publish in the future.
Co-authors
The 25 scholars most cited alongside Tuyen Bui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 224 | |
| 2 | 2017 | 105 | |
| 3 | 2018 | 81 | |
| 4 | 2016 | 76 | |
| 5 | 2016 | 72 | |
| 6 | Conifer microsatellite handbook. | 2002 | 67 |
| 7 | 2011 | 63 | |
| 8 | 2007 | 62 | |
| 9 | 2016 | 51 | |
| 10 | 2016 | 50 | |
| 11 | 2002 | 45 | |
| 12 | 2009 | 42 | |
| 13 | 2010 | 41 | |
| 14 | 2017 | 41 | |
| 15 | 2013 | 32 | |
| 16 | 2010 | 31 | |
| 17 | 2023 | 27 | |
| 18 | 2021 | 23 | |
| 19 | 2007 | 18 | |
| 20 | 2015 | 17 |
About Tuyen Bui
Tuyen Bui is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cell Biology and Cancer Research, having authored 36 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (19 papers), Advanced Breast Cancer Therapies (12 papers), Microtubule and mitosis dynamics (9 papers), Epigenetics and DNA Methylation (4 papers), DNA Repair Mechanisms (3 papers), Ubiquitin and proteasome pathways (3 papers), RNA modifications and cancer (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (603 citations), Cancer Research (192 citations), Pulmonary and Respiratory Medicine (377 citations), Cell Biology (174 citations) and Molecular Biology (549 citations). Tuyen Bui has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Khandan Keyomarsi, Kelly K. Hunt, Cansu Karakaş, Smruthi Vijayaraghavan, Saïd Akli, Lisa D. Auckland, Yi Zhou, Min Yi, Yang Zhao and Xian Chen. Their work appears in journals such as Cancer Research, Oncogene, Clinical Cancer Research, Molecular Cancer Therapeutics and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.